Advances in clinical research and new form of docetaxel / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 3029-3034, 2016.
Article
in Zh
| WPRIM
| ID: wpr-498450
Responsible library:
WPRO
ABSTRACT
Docetaxel (DXT)is a member of the taxane drug class,which is used to treat breast cancer,lung cancer,gastric cancer,prostate cancer and so on.Docetaxel can be used as a single agent or in combination with other chemotherapeutic drugs.Many side effects of docetaxel have been reported in recent years.New dosage forms are developed to reduce toxicity and increase efficacy.An overview of these novel formulations of docetaxel and clinical progress will be discussed by consulting 43 literatures.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2016
Document type:
Article